Here are 12 key notes from spine and orthopedic device companies.
Spinal Tech
During the 2018 earnings report conference call, Stryker executives spoke in-depth about Mako robotic technology growth and projected additional success in the future, according to a transcript from Seeking Alpha.
Stryker reported 9.4 percent sales growth in 2018, reaching $413 billion for the year.
In 2018, Stryker's spine business increased 18 percent to $2.6 billion in sales, amid the company's $1.4 billion acquisition of K2M.
Spinal fusion procedures are formed in various forms; however, all are designed to help mitigate degenerative disc disease pain.
Advertisement
Stryker's 2018 sales increased 9.3 percent to $413.6 billion, with growth across all lines.
Brian Verrier is the CEO of orthopedic fixation company OSSIO. With 28 years of medtech experience, Mr. Verrier spoke with Becker’s Spine Review about OSSIO’s technology and trends in the orthopedic fixation market.
Johnson & Johnson subsidiary DePuy Synthes plans to create 30 new jobs at its Ireland hub because of a $41.16 million investment, according to the Business Irish.
The FDA granted Zimmer Biomet 510(k) clearance for its ROSA Knee System.
Competitors in the spine devices market are expected to see $3 billion in emerging opportunity through 2022, according to a Fact.MR report. Along with the opportunities, the market is expected to register a 7.1 percent compound annual growth rate during…